Navigation Links
Bavarian Nordic Has Essentially Agreed a Pathway for the Licensure of IMVAMUNE(R) With the FDA After Successful End of Phase II Meeting
Date:3/3/2009

KVISTGAARD, Denmark, March 3 /PRNewswire-FirstCall/ -- Following the completion of the Phase II clinical development of IMVAMUNE(R), a third-generation smallpox vaccine, Bavarian Nordic has held an end of Phase II meeting with the FDA to discuss the Phase III development. The meeting was a success and there was an open and highly constructive discussion with the FDA.

This meeting represented the first ever formal discussions with the agency to license a vaccine under the new legislation of the animal rule - a new regulatory path which allows the efficacy of products for indications like smallpox to be established in suitable animal efficacy models. This marks a major regulatory milestone in the successful development of IMVAMUNE(R).

The animal efficacy models and phase III protocol have essentially been agreed with the agency - outlining a clear path for licensure of IMVAMUNE(R). Once all protocols have been agreed with the FDA a Vaccines Related Biological Product Advisory Committee (VRBPAC) will be scheduled to ratify the license strategy. This exceptional review path will likely push the initiation of the Phase III studies into late 2010, leading to the submission of a BLA in 2013.

The outcome of the meeting has no impact on the delivery of vaccines to the Strategic National Stockpile (SNS) under the RFP-3 contract with the US government, which is still expected to be initiated in 2009.

In clinical trials to-date, IMVAMUNE(R) has shown to be safe and well tolerated in more than 2,400 people including more than 900 immune compromised people, either infected with HIV or diagnosed with atopic dermatitis. These clinical studies have demonstrated that IMVAMUNE(R) induces a fast and strong immune response, which is comparable to that induced by traditional smallpox vaccines. However, the efficacy of IMVAMUNE(R) cannot be established in the clinic, because smallpox no longer exist
'/>"/>

SOURCE Bavarian Nordic A/S
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Bavarian Nordics Case Against Oxford BioMedica
2. Bavarian Nordic Receives USD 25 Million Milestone Payment After Submission of Important IMVAMUNE(R) Data to The U.S. Health Authorities
3. Bavarian Nordic A/S - Interim Report for the Period 1 January to 30 June 2008
4. Bavarian Nordic Update - 2007 Annual Results, IMVAMUNE(R) Delivery Contract, Strategy Process
5. Bavarian Nordic Receives $50 Million Advance Payment from HHS for Fulfilling Contract Milestones
6. The Omega-3 Industry Leader, Croda Health Care, selects Neptune Technologies Ingredients for New Essentially Brand
7. Millipore Launches an Interactive Biological Pathway Tool Using GeneGos Manually Curated Pathway Maps
8. Cardiovascular Side Effects of Pioglitazone and Rosiglitazone Linked to Vascular and Energy Pathways by Genomas Clinical Study
9. GEN Reports Growing Focus on PI3-Kinase Pathway in Cancer Research
10. Debiopharm and Aurigene Sign Licensing Agreement for the Development and Commercialisation of Debio 0617, a Novel Inhibitor of an Undisclosed Oncology Pathway
11. Frost & Sullivan Awards Genpathway 2008 Healthcare Innovation Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Colo. , July 31, 2014 ... awardee today with $25,000 to fund a translational ... inception in 2011, the gift was presented at ... Annual Meeting in Colorado Springs, ... specialize in neurointerventional approaches to neurovascular conditions, SNIS ...
(Date:7/31/2014)... 31, 2014 Rogne Bioscience, a privately-held biotechnology ... , has acquired a licence to anti-inflammatory peptides ... The potent anti-inflammatory activity of the peptides was discovered ... of Oxford,s Sir William Dunn School of ... over $1.5 million in seed financing, is developing a ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 North Shore Towers, ... City, partnered with GI Energy, one of the nation’s leading ... $13 million upgrade of its 43-year-old CHP system. The original ... in an effort to extend the life of the plant, ... and associated electrical and heat recovery equipment, while maintaining continuous ...
(Date:7/31/2014)... , July 31, 2014 Research and ... "Global Genomics Market 2014-2018" report to their offering. ... Genomics is the study of the genetic material or ... a strong basis for the discovery and development of ... diseases or health conditions. Genomics is supported by three ...
Breaking Biology Technology:SNIS Foundation Bestows First Grant Award For Cutting-Edge NeuroInterventional Research 2SNIS Foundation Bestows First Grant Award For Cutting-Edge NeuroInterventional Research 3Oxford licenses anti-inflammatory peptides to San Francisco Bay Area start-up 2Oxford licenses anti-inflammatory peptides to San Francisco Bay Area start-up 3North Shore Towers Partners with GI Energy to Install Turnkey Natural Gas-Fired Combined Heat and Power Plant 2Global Genomics Market 2014-2018: Key Vendors are F. Hoffmann-La Roche, Life Technologies, Qiagen and Illumina 2
... Paratek Pharmaceuticals, Inc.,announced today that it has ... a $40,million private financing. As previously announced, ... by new investors, the D.E. Shaw,group and ... investors,Nomura Phase4 Ventures, Novartis BioVentures, BioFund Ventures, ...
... . , Researchers from the UAB Research Park have ... temperature. A carbon nanotube is capable of transporting cargo and ... smaller than the head of a needle. This research opens ... to carry out mechanical tasks and which could be applied ...
... FIRST QUARTER 2008 FINANCIAL RESULTS, VANCOUVER, April 15 /PRNewswire-FirstCall/ - ... pharmaceutical and,medical device company, will host a conference call discussing its,financial ... Tuesday, April 29, 2008 at 11:00 AM ... Mountain, 10:00 AM Central), Dial information ...
Cached Biology Technology:Paratek Pharmaceuticals Completes $40 Million Private Placement to Finance Clinical Programs Including Oral Antibiotic to Combat MRSA and Other Infections 2Paratek Pharmaceuticals Completes $40 Million Private Placement to Finance Clinical Programs Including Oral Antibiotic to Combat MRSA and Other Infections 3Notice of conference call and webcast 2
(Date:7/30/2014)... Society of America (ESA) has elected ten new Fellows ... Fellow acknowledges outstanding contributions to entomology in one or ... The following Fellows will be recognized during Entomology 2014 ... held November 16-19, 2014 in Portland, Oregon. , ... the Department of Plant, Soil and Entomological Sciences at ...
(Date:7/30/2014)... (SALSI), a joint venture between The University of Texas ... Health Science Center at San Antonio, has selected the ... Emily Boice from UTSA and Lei Huang from the ... titled, "Novel engineered ferritins for tracking and protecting neural ... research is focused on finding a treatment for stroke ...
(Date:7/30/2014)... -- A study of dominance in female baboons suggests that ... ties with mom, and to have lots of supportive sisters. ... size or strength, but by the rank of her mother ... daughter will be. For this reason, dominance rank in female ... to high-ranking mothers are guaranteed a good spot in the ...
Breaking Biology News(10 mins):Entomological Society of America recognizes 2014 fellows 2Entomological Society of America recognizes 2014 fellows 3Entomological Society of America recognizes 2014 fellows 4Entomological Society of America recognizes 2014 fellows 5Entomological Society of America recognizes 2014 fellows 6Entomological Society of America recognizes 2014 fellows 7Entomological Society of America recognizes 2014 fellows 8Entomological Society of America recognizes 2014 fellows 9Entomological Society of America recognizes 2014 fellows 10Entomological Society of America recognizes 2014 fellows 11Entomological Society of America recognizes 2014 fellows 12Entomological Society of America recognizes 2014 fellows 13Entomological Society of America recognizes 2014 fellows 14Entomological Society of America recognizes 2014 fellows 15Entomological Society of America recognizes 2014 fellows 16Entomological Society of America recognizes 2014 fellows 17Supportive moms and sisters boost female baboon's rank 2Supportive moms and sisters boost female baboon's rank 3
... younger. This finding comes out from a study by ... Centres participating to the FLORA Project, a European Commission ... of polyphenols, on human health. The scientific work, ... the few approaching this field by in vivo studies. ...
... The camera you own has one main lens and produces ... hand or view it on your computer screen. On the ... placed apart from each other) can take more interesting 3-D ... world through thousands of tiny lenses, each a miniature camera ...
... across North America have been awarded Leopold Leadership ... Woods Institute for the Environment, the Leopold Leadership ... by the David and Lucile Packard Foundation. Each ... academic environmental scientists as fellows, who receive intensive ...
Cached Biology News:A stronger heart with flavonoids 2A stronger heart with flavonoids 3Stanford researchers developing 3-D camera with 12,616 lenses 2Stanford researchers developing 3-D camera with 12,616 lenses 3Stanford researchers developing 3-D camera with 12,616 lenses 419 researchers selected as 2008 Leopold Leadership Fellows 219 researchers selected as 2008 Leopold Leadership Fellows 319 researchers selected as 2008 Leopold Leadership Fellows 4
...
... imaging system from Molecular Devices ... system for automated acquisition and analysis ... screening. ImageXpressULTRA is powered by ... screening acquisition, image storage and analysis. ...
The Saturn 2200 answers your GC/MS questions with the CP-3800 GC and the 2000 Series Ion Trap MS! These components create a platform for the worlds most versatile GC and flexible MS. Both deliver une...
... MG Phosphate Assay Kit is based on ... Malachite Green, molybdate and free orthophosphate. The ... be conveniently measured on a spectrophotometer (600-660 ... non-radioactive colorimetric assay kits have been optimized ...
Biology Products: